Lanzamiento Enero 2027

Estudio2024Acceso abierto

Intermittent fasting and health outcomes: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials

Sun ML, Yao W, Wang XY, Gao S, Varady KA, Forslund SK, Zhang M, Shi ZY, Cao F, Zou BJ, Sun MH, Liu KX, Bao Q, Xu J, Qin X, Xiao Q, Wu L, Zhao YH, Zhang DY, Wu QJ, Gong TT

EClinicalMedicine · 71 citas

Cómo se estudió

Diseño
Metaanálisis (clasificado por nuestro filtro de IA)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Natural Science Foundation of China
Universidad u hospital
China Medical University
Gobierno
National Key Research and Development Program of China
Universidad u hospital
Shengjing Hospital
Subvenciones
National Key Research and Development Program of China (2022YFC2704205); National Natural Science Foundation of China (82373674); National Natural Science Foundation of China (82073647); National Natural Science Foundation of China (2022YFC2704205); National Natural Science Foundation of China (82103914)

Según 4 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2024-03-11 · EClinicalMedicine · vol. 70 · pág. 102519
Editorial
Elsevier BV
Citado
94 citas · más que el 99% de estudios similares · 7.9× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
109 trabajos
Acceso
Acceso abierto (revista) · CC-BY-NC-ND
Áreas de investigación
Dietary Effects on Health · Genetics, Aging, and Longevity in Model Organisms · Diet and metabolism studies
Palabras clave
Medicine, Meta-analysis, Systematic review, Randomized controlled trial, MEDLINE, Alternative medicine, Physical therapy, Surgery, Internal medicine, Pathology

21 autores

  • Mingli Sun🇨🇳China Medical University
  • Wei Yao🇨🇳China Medical University
  • Xiaoying Wang🇨🇳China Medical University
  • Song Gao🇨🇳China Medical University
  • Krista A Varady🇺🇸University of Illinois Chicago
  • Sofia Kirke Forslund🇩🇪Max Delbrück Center; Humboldt-Universität zu Berlin; German Centre for Cardiovascular Research; Freie Universität Berlin; Charité - Universitätsmedizin Berlin
  • Miao Zhang🇨🇳China Medical University
  • Zan-Yu Shi🇨🇳China Medical University
  • Fan Cao🇨🇳China Medical University
  • Bing-Jie Zou🇨🇳China Medical University
  • Ming-Hui Sun🇨🇳China Medical University
  • Kexin Liu🇨🇳China Medical University
  • Qi Bao🇨🇳China Medical University
  • Xu Jin🇨🇳China Medical University
  • Qin Xue🇨🇳China Medical University
  • Qian Xiao🇨🇳China Medical University
  • Lang Wu🇺🇸University of Hawaiʻi at Mānoa; University of Hawaii System
  • Yuhong Zhao🇨🇳 · autor de correspondenciaChina Medical University
  • Deyu Zhang🇨🇳 · autor de correspondenciaChina Medical University
  • Qi‐Jun Wu🇨🇳 · autor de correspondenciaNational Health and Family Planning Commission; China Medical University
  • Ting‐Ting Gong🇨🇳 · autor de correspondenciaChina Medical University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Benefits of Intermittent fasting (IF) on health-related outcomes have been found in a range of randomised controlled trials (RCTs). Our umbrella review aimed to systematically analyze and synthesize the available causal evidence on IF and its impact on specific health-related outcomes while evaluating its evidence quality.

Methods

We comprehensively searched the PubMed, Embase, Web of Science, and Cochrane databases (from inception up to 8 January 2024) to identify related systematic reviews and meta-analyses of RCTs investigating the association between IF and human health outcomes. We recalculated the effect sizes for each meta-analysis as mean difference (MD) or standardized mean difference (SMD) with corresponding 95% confidence intervals (CIs). Subgroup analyses were performed for populations based on three specific status: diabetes, overweight or obesity, and metabolic syndrome. The quality of systematic reviews was evaluated using A Measurement Tool to Assess Systematic Reviews (AMSTAR), and the certainty of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) system. This study is registered with PROSPERO (CRD42023382004).

Findings

A total of 351 associations from 23 meta-analyses with 34 health outcomes were included in the study. A wide range of outcomes were investigated, including anthropometric measures (n = 155), lipid profiles (n = 83), glycemic profiles (n = 57), circulatory system index (n = 41), appetite (n = 9), and others (n = 6). Twenty-one (91%) meta-analyses with 346 associations were rated as high confidence according to the AMSTAR criteria. The summary effects estimates were significant at p p = 0.038), fat mass (MD = -0.72 kg; 95% CI: -1.32 to -0.12; p = 0.019), fasting insulin (SMD = -0.21; 95% CI: -0.40 to -0.02; p = 0.030), low-density lipoprotein cholesterol (LDL-C) (SMD = -0.20; 95% CI: -0.38 to -0.02; p = 0.027), total cholesterol (TC) (SMD = -0.29; 95% CI: -0.48 to -0.10; p = 0.003), and triacylglycerols (TG) (SMD = -0.23; 95% CI: -0.39 to -0.06; p = 0.007), but increased fat free mass (FFM) (MD = 0.98 kg; 95% CI: 0.18-1.78; p = 0.016). Of note, compared with the non-intervention diet, modified alternate-day fasting (MADF) reduced fat mass (MD = -0.70 kg; 95% CI: -1.38 to -0.02; p = 0.044). In people with overweight or obesity, and type 2 diabetes, IF increases high-density lipoprotein cholesterol (HDL-C) levels compared to continuous energy restriction (CER) (MD = 0.03 mmol/L; 95% CI: 0.01-0.05; p = 0.010). However, IF was less effective at reducing systolic blood pressure (SBP) than a CER diet in adults with overweight or obesity (SMD = 0.21; 95% CI: 0.05-0.36; p = 0.008).

Interpretation

Our findings suggest that IF may have beneficial effects on a range of health outcomes for adults with overweight or obesity, compared to CER or non-intervention diet. Specifically, IF may decreased WC, fat mass, LDL-C, TG, TC, fasting insulin, and SBP, while increasing HDL-C and FFM. Notably, it is worth noting that the SBP lowering effect of IF appears to be weaker than that of CER.

Funding

This work was supported by the National Key Research and Development Program of China (Q-JW), the Natural Science Foundation of China (Q-JW and T-TG), Outstanding Scientific Fund of Shengjing Hospital of China Medical University (Q-JW), and 345 Talent Project of Shengjing Hospital of China Medical University (T-TG).

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.